Actuate Therapeutics (ACTU) plans to raise $50 million in an initial public offering on the week of June 24th,...
Read morePteroDynamics Inc, an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, today announced that veteran aviation industry program...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a...
Read moreActuate Therapeutics plans to sell nearly 5.56 million shares at between $8 and $10 apiece in its initial public...
Read morePteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, today announced that Joshua Roth has...
Read moreResearchers at Neuro-Bio Ltd in collaboration with an international team of clinicians and neuroscientists have published a new perspective...
Read moreActuate Therapeutics, a Phase 2 biotech developing in-licensed inhibitor therapies for difficult to treat cancers, filed on Friday with...
Read moreMemVerge in collaboration with Micron and SuperMicro showcased a remarkable breakthrough in computing at Nvidia’s GTC conference. MemVerge demonstrated...
Read moreVivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...
Read moreClearsense, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it...
Read more